-
Volunteers for the trial put an arm over a box with hundreds of mosquitoes carrying a genetically modified malaria parasite. Here's why they did it that way — and why the trial holds promise.
-
Resistance to the drug artemisinin was confirmed in Africa. Without better surveillance, experts say it is hard to track the threat.
-
The vaccine is called Mosquirix, a nod to the mosquitos that spread the malaria parasite when they bite.
-
It's also the first vaccine against a parasitic disease in humans. But there are issues to consider, from its rate of effectiveness to the dosage schedule.
-
Did you even know the U.S. has a malaria czar? Who himself had malaria as a kid? We interview Dr. Raj Panjabi, newly appointed by President Joe Biden.
-
It all started when a London primary school asked children to bring in a plastic tube containing approximately one tablespoon of homemade soup.
-
Mutant parasites have built up resistance to first-line malaria drugs, according to two new studies in The Lancet. Scientists worry that this could overturn global progress against the disease.
-
The modified fungus produces spider toxin that rapidly kills mosquitoes, raising hopes for a new weapon to fight a disease that sickens millions. But not everyone is convinced.
-
Artemisinin-based medications have long been the treatment of choice for malaria. But late in 2015, health officials in Britain came across a cluster of cases that refused to succumb to the drugs.
-
A powerful genetic engineering technique holds promise for wiping out diseases and improving agriculture. But the species-altering approach stirs anxiety about unintended consequences.